Sedman AJ - Search Results

1

Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease.

Sedman AJ, Bockbrader H, Schwarz RD. Sedman AJ, et al. Life Sci. 1995;56(11-12):877-82. doi: 10.1016/0024-3205(95)00023-y. Life Sci. 1995. PMID: 10188788 Clinical Trial.

2

Safety and tolerability of CI-979 in patients with Alzheimer's disease.

Sramek JJ, Sedman AJ, Reece PA, Hourani J, Bockbrader H, Cutler NR. Sramek JJ, et al. Among authors: sedman aj. Life Sci. 1995;57(5):503-10. doi: 10.1016/0024-3205(95)00283-c. Life Sci. 1995. PMID: 7623616 Clinical Trial.

3

Effects of age and gender on single-dose pharmacokinetics of gabapentin.

Boyd RA, Türck D, Abel RB, Sedman AJ, Bockbrader HN. Boyd RA, et al. Among authors: sedman aj. Epilepsia. 1999 Apr;40(4):474-9. doi: 10.1111/j.1528-1157.1999.tb00743.x. Epilepsia. 1999. PMID: 10219274 Free article. Clinical Trial.

4

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN. Randinitis EJ, et al. Among authors: sedman aj. J Clin Pharmacol. 2003 Mar;43(3):277-83. doi: 10.1177/0091270003251119. J Clin Pharmacol. 2003. PMID: 12638396 Clinical Trial.

5

Lack of interaction of gabapentin with carbamazepine or valproate.

Radulovic LL, Wilder BJ, Leppik IE, Bockbrader HN, Chang T, Posvar EL, Sedman AJ, Uthman BM, Erdman GR. Radulovic LL, et al. Among authors: sedman aj. Epilepsia. 1994 Jan-Feb;35(1):155-61. doi: 10.1111/j.1528-1157.1994.tb02926.x. Epilepsia. 1994. PMID: 8112239

6

Effect of cimetidine administration on the pharmacokinetics of pirmenol.

Stringer KA, Lebsack ME, Cetnarowski-Cropp AB, Goldfarb AL, Radulovic LL, Bockbrader HN, Chang T, Sedman AJ. Stringer KA, et al. Among authors: sedman aj. J Clin Pharmacol. 1992 Jan;32(1):91-4. doi: 10.1002/j.1552-4604.1992.tb03794.x. J Clin Pharmacol. 1992. PMID: 1740542

7

Disposition of gabapentin in anuric subjects on hemodialysis.

Wong MO, Eldon MA, Keane WF, Türck D, Bockbrader HN, Underwood BA, Sedman AJ, Halstenson CE. Wong MO, et al. Among authors: sedman aj. J Clin Pharmacol. 1995 Jun;35(6):622-6. doi: 10.1002/j.1552-4604.1995.tb05020.x. J Clin Pharmacol. 1995. PMID: 7665723

8

Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans.

Reece PA, Sedman AJ, Rose S, Wright DS, Dawkins R, Rajagopalan R. Reece PA, et al. Among authors: sedman aj. J Clin Pharmacol. 1994 Nov;34(11):1126-32. doi: 10.1002/j.1552-4604.1994.tb01991.x. J Clin Pharmacol. 1994. PMID: 7876406 Clinical Trial.

9

Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects.

Posvar EL, Radulovic LL, Cilla DD Jr, Whitfield LR, Sedman AJ. Posvar EL, et al. Among authors: sedman aj. J Clin Pharmacol. 1996 Aug;36(8):728-31. doi: 10.1002/j.1552-4604.1996.tb04242.x. J Clin Pharmacol. 1996. PMID: 8877677 Clinical Trial.

10

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.

Cilla DD Jr, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL. Cilla DD Jr, et al. Among authors: sedman aj. Clin Pharmacol Ther. 1996 Dec;60(6):687-95. doi: 10.1016/S0009-9236(96)90218-0. Clin Pharmacol Ther. 1996. PMID: 8988072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page